Search for Companies, Tipsters or Sources…
Companies
Tipsters
Brokers
Sources
Or view the latest share tips
Company Results
Tipster results
Broker results
Sources results
Fund Manager results
Tips from these results
Recent Share tips:
- Sell Tribe Technology (TRYB) by Steve Moore in ShareProphets
- Sell Seeing Machines Ltd. NPV (DI) (SEE) by Steve Moore in ShareProphets
- Sell Quiz (QUIZ) by Steve Moore in ShareProphets
- Buy Croda International (CRDA) by Tom Winnifrith in ShareProphets
- Buy British American Tobacco (BATS) by Mark David Hartley in The Motley Fool
- Buy Diageo (DGE) by Stephen Wright in The Motley Fool
- Buy Taylor Wimpey (TW.) by Harvey Jones in The Motley Fool
- Avoid Inspects Group (SPEC) by Steve Moore in ShareProphets
- Buy Zotefoams (ZTF) by Hot Stock Rockets in ShareProphets
- Neutral Ceres Power Holdings (CWR) by Goldman Sachs
- Sell Bunzl (BNZL) by Goldman Sachs
- Buy Anglo American (AAL) by Stephen Wright in The Motley Fool
- Hold AstraZeneca (AZN) by Ben McPoland in The Motley Fool
- Hold BAE Systems (BA.) by Ben McPoland in The Motley Fool
- Buy Land Securities Group (LAND) by Robert Stephens (Telegraph) in The Telegraph - Questor
- Buy Greggs (GRG) by Ben McPoland in The Motley Fool
- Sell Inspired (INSE) by Steve Moore in ShareProphets
- Neutral Schroders (SDR) by JP Morgan
- Sell Jaywing (JWNG) by Steve Moore in ShareProphets
- Sell Jubilee Metals Group (JLP) by Tom Winnifrith in ShareProphets
Renalytix (Reg S) (RENX) Share Price
Health Care Sector
NOTE: This is based on 14 open tips for Renalytix (Reg S) (RENX)
| Latest Bid : 10.50p | Latest Ask : 11.00p |
| High Today : 10.97p | Low Today : 10.15p |
| This Years High : 50.40p | This Years Low : 6.75p |
| Volume : 957,007 | MKT Cap : £20.32M |
| Trading Velocity : Premium Only | Activity Score : Premium Only |
| Consensus Score : Premium Only | Momentum Score : Premium Only |
Renalytix (Reg S) (RENX) Overview
RenalytixAI is a developer of artificial intelligence (AI) enabled clinical decision support solutions for kidney disease, one of the most common and costly chronic medical conditions globally. RenalytixAI's solutions are being designed to make significant improvements in kidney disease risk assessment, clinical care and patient stratification for drug clinical trials.Renalytix (Reg S) (RENX) Latest Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Sell | Steve Moore | Premium Only | 2024-08-21 16:20:00 21/08/2024 | -2.38% |
| Add | Christopher Ruane | Premium Only | 2022-06-30 13:50:00 30/06/2022 | -91.40% |
| Buy | Christopher Ruane | Premium Only | 2022-02-23 17:40:00 23/02/2022 | -96.75% |
| Buy | Christopher Ruane | Premium Only | 2022-02-16 11:55:00 16/02/2022 | -97.44% |
| Buy | Christopher Ruane | Premium Only | 2022-01-26 17:40:00 26/01/2022 | -97.78% |
Renalytix (Reg S) (RENX) Active Short Positions
| Fund Manager | Position | Date |
|---|---|---|
| Citadel Securities GP LLC | 0.58% | 30/08/2024 |
| Armistice Capital LLC | 0.52% | 26/07/2024 |
| Latest Bid : 10.50p | Latest Ask : 11.00p |
| High Today : 10.97p | Low Today : 10.15p |
| This Years High : 50.40p | This Years Low : 6.75p |
| Volume : 957,007 | MKT Cap : £20.32M |
Renalytix (Reg S) Overview
RenalytixAI is a developer of artificial intelligence (AI) enabled clinical decision support solutions for kidney disease, one of the most common and costly chronic medical conditions globally. RenalytixAI's solutions are being designed to make significant improvements in kidney disease risk assessment, clinical care and patient stratification for drug clinical trials.NOTE: This description is in part generated by ChatGPT and not an endorsement by or the opinion of Stockomendation Ltd.
Latest Renalytix (Reg S) Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Sell | Steve Moore | Premium Only | 2024-08-21 16:20:00 21/08/2024 | -2.38% |
| Add | Christopher Ruane | Premium Only | 2022-06-30 13:50:00 30/06/2022 | -91.40% |
| Buy | Christopher Ruane | Premium Only | 2022-02-23 17:40:00 23/02/2022 | -96.75% |
| Buy | Christopher Ruane | Premium Only | 2022-02-16 11:55:00 16/02/2022 | -97.44% |
| Buy | Christopher Ruane | Premium Only | 2022-01-26 17:40:00 26/01/2022 | -97.78% |